High‐performance thermal insulating aerogels are attractive candidates for thermal protection in extreme environments. However, inorganic aerogels’ brittleness and poor machinability limit their ...applications, while organic aerogels suffer from severe strength degradation and structural collapse at high temperatures. Herein, for the first time, a thermo‐responsive self‐ceramifiable aerogel is demonstrated with exceptional strengthening and thermal insulation at high temperatures. This aerogel exhibits excellent toughness and processability like polymers under normal conditions but spontaneously transforms into high‐strength semi‐crystalline hard ceramics upon exposure to high temperatures. After prolonged thermal attack at 800 °C, the strength of the aerogels does not decrease but significantly increases several‐fold (from 0.739 to 2.726 MPa). The self‐ceramization behavior and mechanism of the aerogel are illustrated in detail. The unique self‐ceramifiable capacity enables aerogels to provide fire resistance, high‐strength support, and excellent thermal insulation at ultrahigh temperatures. Even with continuous burning at 1300 °C for 60 min, the 15 mm thick aerogel shows low backside temperature below 300 °C, crack‐free overall structure, and invariant porous morphology. This self‐ceramifiable aerogel opens up a new avenue for developing thermal‐protection materials with toughness, machinability, high strength, and thermal insulation in extreme environments.
A new thermo‐responsive self‐ceramifiable aerogel is for the first time reported with exceptional strengthening and thermal insulation at high temperatures. Under normal conditions, the aerogel exhibits excellent toughness and machinability. Upon exposure to high temperatures, the aerogel spontaneously and rapidly transforms into robust semi‐crystalline hard ceramics, thus leading to fire resistance, high strength, and thermal insulation in extreme environments.
Since December 2019, an epidemic caused by novel coronavirus (2019-nCoV) infection has occurred unexpectedly in China. As of 8 pm, 31 January 2020, more than 20 pediatric cases have been reported in ...China. Of these cases, ten patients were identified in Zhejiang Province, with an age of onset ranging from 112 days to 17 years. Following the latest
National recommendations for diagnosis and treatment of pneumonia caused by 2019-nCoV
(the 4th edition) and current status of clinical practice in Zhejiang Province, recommendations for the diagnosis and treatment of respiratory infection caused by 2019-nCoV for children were drafted by the National Clinical Research Center for Child Health, the National Children’s Regional Medical Center, Children’s Hospital, Zhejiang University School of Medicine to further standardize the protocol for diagnosis and treatment of respiratory infection in children caused by 2019-nCoV.
The detrimental hydrogen evolution side reaction is one of the major issues hindering the commercialization of Zn metal anode in high‐safety and low‐cost rechargeable aqueous batteries. Herein, the ...authors present a Sn alloying approach to effectively inhibit the hydrogen evolution and dendrite growth of the Zn metal anode. Through in situ monitoring of the hydrogen production during repeated plating/stripping tests, it is quantitatively demonstrated that the hydrogen evolution of alloy electrode with appropriate Sn amount is only half of that of pure Zn electrode. Furthermore, the Sn alloying allows for favorable Zn nucleation sites, lowering the Zn nucleation energy barrier and promoting more uniform Zn deposition. The Zn‐Sn alloy electrode offers much‐improved plating/stripping cycling, that is, over 240 h at 5 mA cm−2 and 35.2% depth of discharge. This work provides a practically viable strategy to stabilize Zn metal electrode in rechargeable aqueous batteries.
A Sn alloying approach is demonstrated to effectively inhibit hydrogen evolution and dendrite growth in the Zn metal anode, which is evidenced by precisely quantitative in situ measurement of the hydrogen production during the repeated Zn plating/stripping process.
Interferon-α2b Treatment for COVID-19 Zhou, Qiong; Chen, Virginia; Shannon, Casey P ...
Frontiers in immunology,
05/2020, Letnik:
11
Journal Article
Recenzirano
Odprti dostop
The global pandemic of COVID-19 cases caused by infection with SARS-CoV-2 is ongoing, with no approved antiviral intervention. We describe here the effects of treatment with interferon (IFN)-α2b in a ...cohort of confirmed COVID-19 cases in Wuhan, China. In this uncontrolled, exploratory study, 77 adults hospitalized with confirmed COVID-19 were treated with either nebulized IFN-α2b (5 mU b.i.d.), arbidol (200 mg t.i.d.) or a combination of IFN-α2b plus arbidol. Serial SARS-CoV-2 testing along with hematological measurements, including cell counts, blood biochemistry and serum cytokine levels, and temperature and blood oxygen saturation levels, were recorded for each patient during their hospital stay. Treatment with IFN-α2b with or without arbidol significantly reduced the duration of detectable virus in the upper respiratory tract and in parallel reduced duration of elevated blood levels for the inflammatory markers IL-6 and CRP. These findings suggest that IFN-α2b should be further investigated as a therapy in COVID-19 cases.
To our knowledge, no randomised study has compared postmastectomy hypofractionated radiotherapy with conventional fractionated radiotherapy in patients with breast cancer. This study aimed to ...determine whether a 3-week schedule of postmastectomy hypofractionated radiotherapy is as efficacious and safe as a 5-week schedule of conventional fractionated radiotherapy.
This randomised, non-inferiority, open-label, phase 3 study was done in a single academic hospital in China. Patients aged 18–75 years who had undergone mastectomy and had at least four positive axillary lymph nodes or primary tumour stage T3–4 disease were eligible to participate. Patients were randomly assigned (1:1) according to a computer-generated central randomisation schedule, without stratification, to receive chest wall and nodal irradiation at a dose of 50 Gy in 25 fractions over 5 weeks (conventional fractionated radiotherapy) or 43·5 Gy in 15 fractions over 3 weeks (hypofractionated radiotherapy). The modified intention-to-treat population (including all eligible patients who underwent randomisation but excluding those who were considered ineligible or withdrew consent after randomisation) was used in primary and safety analyses. The primary endpoint was 5-year locoregional recurrence, and a 5% margin was used to establish non-inferiority (equivalent to a hazard ratio <1·883). This trial is registered at ClinicalTrials.gov, number NCT00793962.
Between June 12, 2008, and June 16, 2016, 820 patients were enrolled and randomly assigned to the conventional fractionated radiotherapy group (n=414) or hypofractionated radiotherapy group (n=406). 409 participants in the conventional fractionated radiotherapy group and 401 participants in the hypofractionated radiotherapy group were included in the modified intention-to-treat analyses. At a median follow-up of 58·5 months (IQR 39·2–81·8), 60 (7%) patients had developed locoregional recurrence (31 patients in the hypofractionated radiotherapy group and 29 in the conventional fractionated radiotherapy group); the 5-year cumulative incidence of locoregional recurrence was 8·3% (90% CI 5·8–10·7) in the hypofractionated radiotherapy group and 8·1% (90% CI 5·4–10·6) in the conventional fractionated radiotherapy group (absolute difference 0·2%, 90% CI −3·0 to 2·6; hazard ratio 1·10, 90% CI 0·72 to 1·69; p<0·0001 for non-inferiority). There were no significant differences between the groups in acute and late toxicities, except that fewer patients in the hypofractionated radiotherapy group had grade 3 acute skin toxicity than in the conventional fractionated radiotherapy group (14 3% of 401 patients vs 32 8% of 409 patients; p<0·0001).
Postmastectomy hypofractionated radiotherapy was non-inferior to and had similar toxicities to conventional fractionated radiotherapy in patients with high-risk breast cancer. Hypofractionated radiotherapy could provide more convenient treatment and allow providers to treat more patients.
National Key Projects of Research and Development of China; the Chinese Academy of Medical Science Innovation Fund for Medical Sciences; and Beijing Marathon of Hope, Cancer Foundation of China.
Disordered metabolic states, which are characterised by hypoxia and elevated levels of metabolites, particularly lactate, contribute to the immunosuppression in the tumour microenvironment (TME). ...Excessive lactate secreted by metabolism-reprogrammed cancer cells regulates immune responses via causing extracellular acidification, acting as an energy source by shuttling between different cell populations, and inhibiting the mechanistic (previously ‘mammalian’) target of rapamycin (mTOR) pathway in immune cells. This review focuses on recent advances in the regulation of immune responses by lactate, as well as therapeutic strategies targeting lactate anabolism and transport in the TME, such as those involving glycolytic enzymes and monocarboxylate transporter inhibitors. Considering the multifaceted roles of lactate in cancer metabolism, a comprehensive understanding of how lactate and lactate-targeting therapies regulate immune responses in the TME will provide insights into the complex relationships between metabolism and antitumour immunity.
Triboelectric nanogenerators (TENGs), which hold great promise for sustainably powering wearable electronics by harvesting distributed mechanical energy, are still severely limited by their ...unsatisfactory power density, small capacitance, and high internal impedance. Herein, a materials optimization strategy is proposed to achieve a high performance of TENGs and to lower the matching impedance simultaneously. A permittivity-tunable electret composite film, i.e., a thermoplastic polyurethane (TPU) matrix with polyethylene glycol (PEG) additives and polytetrafluoroethylene (PTFE) nanoparticle inclusions, is employed as the triboelectric layer. Through optimizing the dielectric constant of the composite, the injected charge density and internal capacitance of the TENG are significantly enhanced, thus synergistically boosting the output power and reducing the impedance of the TENG. The optimal output power reaches 16.8 mW at an external resistance of 200 kΩ, showing a 17.3 times enhancement in output power and a 90% decline in matching impedance. This work demonstrates a significant progress toward the materials optimization of a triboelectric generator for its practical commercialization.
Kidney, bladder, and prostate cancer are the three major tumor types of the urologic system that seriously threaten human health. Circular RNAs (CircRNAs), special non-coding RNAs with a stabile ...structure and a unique back-splicing loop-forming ability, have received recent scientific attention. CircRNAs are widely distributed within the body, with important biologic functions such as sponges for microRNAs, as RNA binding proteins, and as templates for regulation of transcription and protein translation. The abnormal expression of circRNAs in vivo is significantly associated with the development of urologic tumors. CircRNAs have now emerged as potential biomarkers for the diagnosis and prognosis of urologic tumors, as well as targets for the development of new therapies. Although we have gained a better understanding of circRNA, there are still many questions to be answered. In this review, we summarize the properties of circRNAs and detail their function, focusing on the effects of circRNA on proliferation, metastasis, apoptosis, metabolism, and drug resistance in kidney, bladder, and prostate cancers.
A challenging direct asymmetric catalytic aerobic oxidative cross‐coupling of 2‐naphthylamine and 2‐naphthol, using a novel CuI/SPDO system, has been successfully developed for the first time. ...Enantioenriched 3,3′‐disubstituted NOBINs were achieved and could be readily derived to divergent chiral ligands and catalysts. This reaction features high enantioselectivities (up to 96 % ee) and good yields (up to 80 %). The DFT calculations suggest that the F–H interactions between CF3 of L17 and H‐1,8 of 2‐naphthol, and the π–π stacking between the two coupling partners could play vital roles in the enantiocontrol of this cross‐coupling reaction.
We describe a challenging and straightforward asymmetric catalytic aerobic oxidative cross‐coupling of 2‐naphthylamine and 2‐naphthol by using a CuI/SPDO/air system. Optically pure 3,3′‐disubstituted NOBINs were achieved that could be readily derived to divergent chiral ligands/catalysts. Mechanistic studies and DFT calculations give a comprehensive understanding of the high enantioselectivity and good chemoselectivity.
PDF
